Lead neurotoxicity in Children: Knowledge gaps and research needs

Human Developmental Neurotoxicology

Volumn , Issue , 2006, Pages 67-82

  Bellinger, David C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34147117268     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (102)

1. Lin-Fu JS. Lead poisoning and undue lead exposure in children: history and current status. In: Needleman HL, ed. Low Level Lead Exposure: The Clinical Implications of Current Research. New York: Raven Press, 1980:5-16.
2. Byers RK, Lord EE. Late effects of lead poisoning on mental development. Am J Dis Child 1943; 66:471-194.
3. Lin-Fu JS. Modern history of lead poisoning: a century of discovery and rediscovery. In: Needleman HL, ed. Human Lead Exposure. Boca Raton: CRC Press, 1992:23-13.
4. Bradley JE, Powell AE, Niermann W, McGrady JR, Kaplan E. The incidence of abnormal levels of lead in a metropolitan pediatric clinic. J Pediatr 1956; 49:1-6.
5. Lin-Fu JS. Undue absorption of lead among children- a new look at an old problem. N Engl J Med 1972; 286:702-710.
6. Mahaffey KR, Annest JL, Roberts J, Murphy RS. National estimates of blood lead levels: United States, 1976-1980. Association with selected demographic and socioeconomic factors. N Engl J Med 1983; 307:573-579.
7. U.S. Centers for Disease Control. Update: blood lead levels-United States, 1991-1994. Morbid Mortal Wkly Rep 1997; 46:141-146.
8. U.S. Centers for Disease Control. Blood lead levels-United States, 1999-2002. Morbid Mortal Wkly Rep 2005; 54:513-516.
9. Grosse SD, Matte TD, Schwartz J, Jackson RJ. Economic gains resulting from the reduction in children's exposure to lead in the United States. Environ Health Perspect 2002; 110:563-569.
10. Flegal AR, Smith DR. Lead levels in preindustrial humans. N Engl J Med 1992; 326:1293-1294.
11. Mushak P. New directions in the toxicokinetics of human lead exposure. Neurotoxicology 1993; 14:29-42.
12. Stangle DR, Strawderman MS, Smith D, Kuypers M, Strupp BJ. Reductions in blood lead overestimate reductions in brain lead after repeated succimer regiments in a rodent model of childhood lead exposure. Environ Health Perspect 2004; 112:302-308.
13. Cremin JD, Luck ML, Laughlin NK, Smith DR. Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure. Toxicol Appl Pharmacol 1999; 161:283-293.
14. Smith D, Hernandez-Avila M, Tellez-Rojo MM, Mercado A, Hu H. The relationship between lead in plasma and whole blood in women. Environ Health Perspect 2002; 110:263-268.
15. Hernandez-Avila M, Smith D, Meneses F, Sanin LH, Hu H. The influence of bone and blood lead on plasma lead levels in environmentally-exposed adults. Environ Health Perspect 1998; 106:473-477.
16. Bergdahl IA, Vahter M, Counter SA, et al. Lead in plasma and whole blood from lead-exposed children. Environ Res 1999; 80:25-33.
17. Chuang HY, Schwartz J, Gonzalez-Cossio T, et al. Interrelations of lead levels in bone, venous blood, and umbilical cord blood with exogenous lead exposure through maternal plasma lead in peripartum women. Environ Health Perspect 2001; 109:527-532.
18. Roberts JR, Reigart JR, Ebeling M, Hulsey TC. Time required for blood lead levels to decline in nonchelated children. J Toxicol Clin Toxicol 2001; 39:153-160.
19. Pocock S, Smith M, Baghurst PA. Environmental lead and children's intelligence: a systematic review of the epidemiological evidence. BMJ 1994; 309:1189-1197.
20. Canfield RC, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. N Engl J Med 2003; 348:1517-1526.
21. Hu H, Rabinwitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 1998; 106:1-8.
22. Schwartz BS, Stewart WF, Bolla KI, et al. Past adult lead exposure is associated with longitudinal decline in cognitive function. Neurology 2000; 55:1144-1150.
23. Stewart WF, Schwartz BS, Simon D, Kelsey K, Todd AC. ApoE genotype, past adult lead exposure, and neurobehavioral function. Environ Health Perspect 2002; 110:501-505.
24. 109Cd K X ray fluorescence measurements of tibial lead content in young adults exposed to lead in early childhood. Occup Environ Med 2000; 57:465-471.
25. Korrick SA, Hunter DJ, Rotnitsky A, Hu H, Speizer FE. Lead and hypertension in a sample of middle-aged women. Am J Public Health 1999; 89:330-335.
26. Gonzalez-Cossio T, Peterson KE, Sanin L, et al. Decrease in birth weight in relation to maternal bone lead burden. Pediatrics 1997; 100:856-862.
27. Sanin LH, Gonzalez-Cossio T, Romieu I, et al. Effect of maternal lead burden on infant weight and weight gain at one month of age among breastfed infants. Pediatrics 2001; 107:1016-1023.
28. Hernandez-Avila M, Peterson KE, Gonzalez-Cossio T, et al. Effect of maternal bone lead on length and head circumference at birth. Arch Environ Health 2002; 57:482-188.
29. Gomaa A, Hu H, Bellinger D, et al. Maternal bone lead as an independent risk factor for fetal neurotoxicity: a prospective study. Pediatrics 2002; 110:110-118.
30. Wasserman GA, Factor-Litvak P, Liu X, et al. The relationship between blood lead, bone lead, and child intelligence. Child Neuropsychol 2003; 9:22-34.
31. Gulson BL. Tooth analyses of sources and intensity of lead exposure in children. Environ Health Perspect 1996; 104:306-312.
32. Needleman HL, McFarland C, Ness RB, Fineberg SE, Tobin MJ. Bone lead levels in adjudicated delinquents: a case-control study. Neurotoxicol Teratol 2002; 24:711-717.
33. Aufderheide AC, Wittmers LE. Selected aspects of the spatial distribution of lead in bone. Neurotoxicology 1992; 13:809-820.
34. Trope I, Lopez-Villegas D, Lenkinski RE. Magnetic resonance imaging and spectroscopy of regional brain structure in a 10-yr-old boy with elevated blood lead levels. Pediatrics 1998; 101:E7.
35. Trope I, Lopez-Villegas D, Cecil KM, Lenkinski RE. Exposure to lead appears to selectively alter metabolism of cortical gray matter. Pediatrics 2001; 107:1437-1442.
36. Weisskopf MG, Hu H, Mulkern R, et al. Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning. Environ Health Perspect 2004; 112:620-625.
37. Grandjean P, Budtz-Jorgensen E, Keiding N, Weihe P. Underestimation of risk due to exposure misclassification. Int J Occup Med Environ Health 2004; 17:131-136.
38. Lanphear BP, Dietrich KN, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations < 10μg/dL in US children and adolescents. Public Health Rep 2000; 115:521-529.
39. Chiodo LM, Jacobson SW, Jacobson JL. Neurodevelopmental effects of postnatal lead exposure at very low levels. Neurotoxicol Teratol 2004; 26:359-371.
40. Bellinger DC. Interpreting the literature on lead and child development: the neglected role of the "experimental system." Neurotoxicol Teratol 1995; 17:201-212.
41. Bellinger DC. Future directions for neurobehavioral studies of environmental neurotoxicants. Neurotoxicology 2001; 22:645-656.
42. Strauss ME, Allred LJ. Methodological issues in detecting specific long-term consequences of perinatal drug exposure. Neurobehav Toxicol Teratol 1986; 8:369-373.
43. Mirsky AF, Duncan CC. A nosology of disorders of attention. In: Wasserstein J, Wolf LE, eds. Adult attention deficit disorder: Brain mechanisms and life outcomes. Ann NY Acad Sci 2001;931:17-32.
44. Bellinger D, Hu H, Titlebaum L, Needleman HL. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health 1994; 49:98-105.
45. Canfield RL, Gendle MH, Cory-Slechta DA. Impaired neuropsychological functioning in lead-exposed children. Dev Neuropsychol 2004; 26:513-540.
46. Luciana M. Dopamine-opiate modulations of reward-seeking behavior: implications for the functional assessment of prefrontal development. In: Nelson CA, Luciana M, eds. Handbook of Developmental Cognitive Neuroscience. Cambridge, MA: The MIT Press, 2003:647-662.
47. Rice DC. Behavioral effects of lead: commonalities between experimental and epidemiologic data. Environ Health Perspect 1996; 104:337-351.
48. Cory-Slechta DA. Lead-induced impairments in complex cognitive function: Offerings from experimental studies. Child Neuropsychol 2003; 9:54-75.
49. Needleman HL, Gunnoe C, Leviton A, et al. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 1979; 300:689-695.
50. Yule W, Urbanowicz M-A, Lansdown R, Millar I. Teachers' ratings of children's behaviour in relation to blood lead levels. Brit J Dev Psych 1984; 2:295-305.
51. Thomsen GO, Raab G, Hepburn WS, Hunter R, Fulton M, Laxen DP. Blood-lead levels and children's behaviour: results from the Edinburgh lead study. J Child Psychol Psychiatry 1989; 30:515-528.
52. Bellinger D, Leviton A, Allred E, Rabinowitz M. Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ Res 1994; 66:12-30.
53. Wasserman G, Staghezza-Jaramillo B, Shrout P, Popovac D, Graziano J. The effect of lead exposure on behavior problems in preschool children. Am J Public Health 1998; 88:481-186.
54. Burns J, Baghurst P, Sawyer M, McMichael A, Tong S. Lifetime low-level exposure to environmental lead and children's emotional and behavioral development at ages 11-13 year: The Port Pirie Cohort Study. Am J Epidemiol 1999; 149:740.
55. Needleman HL, Reiss JA, Tobin MJ, Biesecker GE, Greenhouse JB. Bone lead levels and delinquent behavior. JAMA 1996; 275:363-369.
56. Denno DW. Biology and Violence. New York: Cambridge University Press, 1990.
57. Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL. Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol 2001; 23:511-518.
58. Stretesky PB, Lynch MJ. The relationship between lead exposure and homicide. Arch Pediatr Adolesc Med 2001; 155:579-582.
59. Nevin R. How lead exposure relates to temporal changes in, I.Q., violent crime, and unwed pregnancy. Environ Res 2000; 83:1-22.
60. Accardo P, Whitman B, Caul J, Rolfe U. Autism and plumbism. Clin Pediatr 1988; 27:41-14.
61. Cohen DJ, Johnson WT, Caparulo BK. Pica and elevated blood lead level in autistic and atypical children. Am J Dis Child 1976; 130:47-48.
62. Eppright TD, Sanfacon JA, Horwitz EA. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship. Missouri Med 1996; 93:136-138.
63. Schottenfeld R, Cullen M. Organic affective illness associated with lead intoxication. Am J Psychiatry 1984; 141:1423-1426.
64. McCracken J. Lead intoxication psychosis in an adolescent. J Am Acad Child Psychiatry 1987; 26:274-276.
65. Opler MGA, Brown AS, Graziano JH, et al. Prenatal lead exposure, δ-aminolevulinic acid, and schizophrenia. Environ Health Perspect 2004; 112:548-552.
66. Kotok D. Development of children with elevated blood lead levels: a controlled study. J Pediatr 1972; 80:57-61.
67. Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence, and academic achievement: a long-term follow-up study. Pediatrics 1992; 90:855-861.
68. Walkowiak J, Altmann L, Kramer U, et al. Cognitive and sensorimotor functions in 6-year-old children in relation to lead and mercury levels: Adjustment for intelligence and contrast sensitivity in computerized testing. Neurotoxicol Teratol 1998; 20:511-521.
69. Wang CL, Chuang HY, Ho CK, Yang CY, Tsai JL, Wu TN. Relationship between blood lead concentration and learning achievement among primary school children in Taiwan. Environ Res 2002; 89:12-18.
70. Bellinger DC, Needleman HL. Intellectual impairment and blood lead levels. N Engl J Med 2003; 349:500.
71. Calabrese EJ, Baldwin LA. The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci 2001; 62:330-338.
72. Calabrese EJ, Baldwin LA. The hormetic dose-response model is more common than the threshold model in toxicology. Toxicol Sci 2003; 71:246-250.
73. Bellinger D, Sloman J, Leviton A, Rabinowitz M, Needleman HL, Waternaux C. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics 1991; 87:219-227.
74. Wasserman GA, Liu X, Popovac D, et al. The Yugoslavia Prospective Lead Study: contributions of prenatal and postnatal lead exposure to early intelligence. Neurotoxicol Teratol 2000; 81:811-818.
75. Ris MD, Dietrich KN, Succop PA, Berger OG, Bornschein RL. Early exposure to lead and neuropsychological outcome in adolescence. J Int Neuropsychol Soc 2004; 10:261-270.
76. Needleman HL, Schell A, Bellinger D, Leviton A, Allred EA. Long-term effects of childhood exposure to lead at low dose: an 11-year follow-up report. N Engl J Med 1990; 322:83-88.
77. Tong S, Bagurst P, McMichael A, Sawyer M, Mudge J. Lifetime exposure to environmental lead and children's intelligence at 11-13 years: the Port Pirie Cohort Study. BMJ 1996; 312:1569-1575.
78. Fergusson DM, Horwood LJ, Lynskey MT. Early dentine lead levels and educational outcomes at 18 years. J Child Psychol Psychiatry 1997; 38:471-478.
79. Coscia JM, Ris MD, Succop P, Dietrich KN. Cognitive development of lead exposed children from ages 6 to 15: an application of growth curve analysis. Child Neuropsychol 2003; 9:10-21.
80. Rice DC. Behavioral impairment produced by developmental lead exposure: Evidence from primate research. In: Needleman HL, ed. Human Lead Exposure. Boca Raton, FL: CRC Press, 1992:137-152.
81. Rogan WJ, Dietrich KN, Ware JH, et al. The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. N Engl J Med 2001; 344:1421-1426.
82. Dietrich KN, Ware JH, Salganik M, et al. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics 2004; 114:19-26.
83. Stangle D, Strawderman M, Smith D, Strupp BJ. Succimer chelation significantly ameliorates the lasting cognitive and affective dysfunction produced by early lead exposure in a rodent model. Toxicol Sci 2003; 72:128 (abstract).
84. Laughlin NK, Smith DR. Succimer chelation therapy alleviates some lead-induced cognitive impairments in as non-human primate model of childhood lead exposure. Neurotoxicol Teratol 2001; 22:142 (abstract).
85. Bellinger DC. Effect modification in epidemiologic studies of low-level neurotoxicant exposures and health outcomes. Neurotoxicol Teratol 2000; 22:133-140.
86. Diez Roux AV. The study of group-level factors in epidemiology: rethinking variables, study designs, and analytical approaches. Epidemiol Rev 2004; 26:104-111.
87. Rauh VA, Andrews HF, Garfinkel RS. The contribution of maternal age to racial disparities in birthweight: a multilevel perspective. Am J Public Health 2001; 91:1815-1824.
88. Committee on Biological Markers of the National Research Council. Biological markers in environmental health. Environ Health Perspect 1987; 74:3-9.
89. Bradman A, Eskenazi B, Sutton P, Athanasoulis M, Goldman L. Iron deficiency associated with higher blood lead in children living in contaminated environments. Environ Health Perspect 2001; 109:1079-1084.
90. Ruff HA, Markowitz ME, Bijur PE, Rosen JF. Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children. Environ Health Perspect 1996; 104:180-185.
91. Gardner JM, Walker SP, Chang SM, Vutchkov M, Lalor GC. Undernutrition and elevated blood lead levels: effects on psychomotor development among Jamaican children. Public Health Nutr 1998; 1:177-179.
92. Winneke G, Kramer U. Neuropsychological effects of lead in children: interactions with social background variables. Neuropsychobiology 1984; 11:195-204.
93. Bellinger DC, Leviton A, Waternaux C, Needleman HL, Rabinowitz M. Low-level lead exposure, social class, and infant development. Neurotoxicol Teratol 1988; 10:497-503.
94. Bellinger D, Leviton A, Sloman J. Antecedents and correlates of improved cognitive performance in children exposed in utero to low levels of lead. Environ Health Perspect 1990; 89:5-11.
95. Guilarte TR, Toscano CD, McGlothan JL, Weaver SA. Environmental enrichment reverses cognitive and molecular deficits induced by developmental lead exposure. Ann Neurol 2003; 53:50-56.
96. Kamel F, Umbach DM, Lehman TA. Amyotropic lateral sclerosis, lead, and genetic susceptibility: Polymorphisms in the δ-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ Health Perspect 2003; 111:1335-1339.
97. Weaver VM, Schwartz BS, Ahn K-D, et al. Associations of renal function with polymorphisms in the δ-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers. Environ Health Perspect 2003; 111:1613-1619.
98. Wu M-T, Kelsey K, Schwartz J, Sparrow D, Weiss S, Hu H. A δ-aminolevulinic acid dehydratase (ALAD) polymorphism may modify the relationship of low-level lead exposure to uricemia and renal function: the Normative Aging Study. Environ Health Perspect 2003; 111:335-340.
99. Haynes EN, Kalkwarf HJ, Hornung R, Wenstrup R, Dietrich K, Lanphear BP. Vitamin D receptor fok1 polymorphism and blood lead concentration in children. Environ Health Perspect 2003; 111:1665-1669.
100. Schwartz B. Associations of blood lead, dimercaptosuccinic acid-chelatable lead, and tibia lead with polymorphisms in the vitamin D receptor and δ-aminolevulinic acid dehydratase genes. Environ Health Perspect 2000; 108:949-954.
101. Lee BK, Lee GS, Stewart WF, et al. Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect 2001; 109:383-389.
102. Wright RO, Silverman EK, Schwartz J, et al. Association between hemochromatosis genotype and lead exposure among elderly men: the Normative Aging Study. Environ Health Perspect 2004; 112:746-750.